{"id": "1349545068538032128", "creation": 1610591592.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "$JPM is Neutral on Moderna - Future Position of COVID-19 Vaccine Debated\n\nAnalysts &amp; #investors are most concerned about $MRNA supply orders for its #COVID19 #vaccine past the 500M plus doses committed to in 2021.\n\n$AZN #MRK $GSK $JNJ investing\n\nhttps://t.co/lyGpvMfxXP", "first_save": 1634559108.199414, "hashtags": ["#INVESTORS", "#COVID19", "#VACCINE", "#MRK"]}